Bicycle Therapeutics plc (BCYC)
NASDAQ: BCYC · Real-Time Price · USD
8.18
-0.04 (-0.49%)
Oct 29, 2025, 4:00 PM EDT - Market closed
Bicycle Therapeutics Employees
Bicycle Therapeutics had 305 employees as of December 31, 2024. The number of employees increased by 21 or 7.39% compared to the previous year.
Employees
305
Change (1Y)
21
Growth (1Y)
7.39%
Revenue / Employee
$63,216
Profits / Employee
-$794,630
Market Cap
566.93M
Employees Chart
Employees History
| Date | Employees | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 305 | 21 | 7.39% |
| Dec 31, 2023 | 284 | 48 | 20.34% |
| Dec 31, 2022 | 236 | 117 | 98.32% |
| Dec 31, 2021 | 119 | 32 | 36.78% |
| Dec 31, 2020 | 87 | 15 | 20.83% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| UnitedHealth Group | 400,000 |
| Johnson & Johnson | 138,100 |
| Thermo Fisher Scientific | 125,000 |
| Abbott Laboratories | 114,000 |
| AstraZeneca | 92,900 |
| Novo Nordisk | 77,349 |
| Novartis AG | 75,883 |
| Merck & Co. | 75,000 |
BCYC News
- 14 days ago - Bicycle Therapeutics: Looking For Their Niche, Addressing Cash Burn - Seeking Alpha
- 7 weeks ago - Bicycle Therapeutics Plc (BCYC) Presents At Morgan Stanley 23rd Annual Global Healthcare Conference Transcript - Seeking Alpha
- 7 weeks ago - Bicycle Therapeutics Strengthens Board of Directors with New Appointments - Business Wire
- 2 months ago - Bicycle Therapeutics Reports Recent Business Progress and Second Quarter 2025 Financial Results - Business Wire
- 4 months ago - Bicycle Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - Business Wire
- 5 months ago - Bicycle Therapeutics Announces Poster Presentations at the 2025 ASCO Annual Meeting - Business Wire
- 6 months ago - Bicycle Therapeutics Reports Recent Business Progress and First Quarter 2025 Financial Results - Business Wire
- 6 months ago - Bicycle Therapeutics Announces Presentation of Additional Human Radiopharmaceutical Imaging Data for MT1-MMP at the American Association for Cancer Research Annual Meeting 2025 - Business Wire